Moon, H.H.; Kearney, M.; Mahmoudpour, S.H.; Ike, C.; Morris, V.; Rava, A.; Kim, S.; Sun, H.; Boyd, M.; Gomez Rey, G.
Real-World Treatment Patterns, Sequencing, and Outcomes in Patients with Locally Advanced or Metastatic Urothelial Carcinoma Receiving Avelumab First-Line Maintenance in the United States. Curr. Oncol. 2024, 31, 5662-5676.
https://doi.org/10.3390/curroncol31090420
AMA Style
Moon HH, Kearney M, Mahmoudpour SH, Ike C, Morris V, Rava A, Kim S, Sun H, Boyd M, Gomez Rey G.
Real-World Treatment Patterns, Sequencing, and Outcomes in Patients with Locally Advanced or Metastatic Urothelial Carcinoma Receiving Avelumab First-Line Maintenance in the United States. Current Oncology. 2024; 31(9):5662-5676.
https://doi.org/10.3390/curroncol31090420
Chicago/Turabian Style
Moon, Helen H., Mairead Kearney, Seyed Hamidreza Mahmoudpour, Chiemeka Ike, Valerie Morris, Andrew Rava, Sonia Kim, Haiyan Sun, Marley Boyd, and Gabriel Gomez Rey.
2024. "Real-World Treatment Patterns, Sequencing, and Outcomes in Patients with Locally Advanced or Metastatic Urothelial Carcinoma Receiving Avelumab First-Line Maintenance in the United States" Current Oncology 31, no. 9: 5662-5676.
https://doi.org/10.3390/curroncol31090420
APA Style
Moon, H. H., Kearney, M., Mahmoudpour, S. H., Ike, C., Morris, V., Rava, A., Kim, S., Sun, H., Boyd, M., & Gomez Rey, G.
(2024). Real-World Treatment Patterns, Sequencing, and Outcomes in Patients with Locally Advanced or Metastatic Urothelial Carcinoma Receiving Avelumab First-Line Maintenance in the United States. Current Oncology, 31(9), 5662-5676.
https://doi.org/10.3390/curroncol31090420
